The treatment took place at the center Aug. 30, according to a Sept. 4 news release from Cooper University Health Care, also based in Camden.
Histotripsy was approved by the FDA in 2023 and uses sound waves to destroy liver tumors, according to the release.
“Histotripsy doesn’t require incisions, has minimal side effects and involves a short recovery time,” Young Ki Hong, MD, head of the surgical oncology division at Cooper University Health Care, said in the release. “Studies show it has a 95% success rate in destroying tumors without harming surrounding tissues.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
